PR Newswire Clinical TrialsOriginal article
InBios' Lyme Detect™ Multiplex ELISA Demonstrates Potential to Streamline Lyme Disease Testing in New UConn Health Study
Data ReadoutpositiveLyme Detect™ Multiplex ELISAPositive
AI Analysis
Summary
InBios International's Lyme Detect™ Multiplex ELISA demonstrated in a UConn Health study that a single-step ELISA approach can streamline Lyme disease testing. The diagnostic test shows potential to improve efficiency in Lyme disease diagnosis.
Clinical Trial Data
Primary Endpoint
Met
Outcome Details
Single-step ELISA approach demonstrates potential to streamline Lyme disease testing
Importance:4/10
Sentiment:
0.60
diagnosticsLyme diseaseELISAinfectious diseaseclinical study
Read the original article
Published by PR Newswire Clinical Trials on September 17, 2026 7:00 AM